Tempest Therapeutics (TPST) Prepaid Assets (2011 - 2026)
Tempest Therapeutics (TPST) posted Prepaid Assets of $355000.0 for Q4 2025, down 39.83% sequentially from $590000.0 in Q3 2025, and down 33.64% YoY from $535000.0 in Q4 2024.
Tempest Therapeutics (TPST) Prepaid Assets (2011 - 2026) Analysis & Trends
Tempest Therapeutics has reported Prepaid Assets for 15 years, with the latest figure at $355000.0 in Q4 2025.
- Quarterly Prepaid Assets fell 33.64% year-over-year to $355000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $355000.0 (down 33.64% YoY) and the FY2025 annual result came in at $355000.0, down 33.64% from the prior year.
- Prepaid Assets retreated to $355000.0 in Q4 2025 per TPST's latest filing, from $590000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $2.8 million in Q3 2021 and troughed at $96000.0 in Q4 2023.
- A 5-year average of $806950.0 and a median of $569000.0 in 2021 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2021 and 2023: Prepaid Assets soared 837.29% in 2021, then slumped 89.76% in 2023.
- Over 5 years, Prepaid Assets stood at $553000.0 in 2021, then grew by 27.12% to $703000.0 in 2022, then plunged by 86.34% to $96000.0 in 2023, then soared by 457.29% to $535000.0 in 2024, then sank by 33.64% to $355000.0 in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $355000.0, $590000.0, and $231000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Tempest Therapeutics | 4.23 Mn | 3.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 918,000.00 |
| Dec 31, 2025 | 355,000.00 |
| Sep 30, 2025 | 590,000.00 |
| Jun 30, 2025 | 231,000.00 |
| Mar 31, 2025 | 356,000.00 |
| Dec 31, 2024 | 535,000.00 |
| Sep 30, 2024 | 385,000.00 |
| Jun 30, 2024 | 272,000.00 |
| Mar 31, 2024 | 585,000.00 |
| Dec 31, 2023 | 96,000.00 |
| Sep 30, 2023 | 232,000.00 |
| Jun 30, 2023 | 393,000.00 |
| Mar 31, 2023 | 594,000.00 |
| Dec 31, 2022 | 703,000.00 |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 691,000.00 |
| Dec 31, 2021 | 553,000.00 |
| Sep 30, 2021 | 2.80 Mn |
| Jun 30, 2021 | 686,000.00 |